| Name | Title | Contact Details |
|---|
Aurora Diagnostics is a leading independent pathology services and cancer diagnostics company, offering integrated diagnostic and personalized medicine consultations and information technology solutions to physicians and hospital systems. Our pathologists provide diagnostic opinions and work collaboratively with referring physicians to determine appropriate patient treatment options. We also provide services to pharmaceutical companies and other research entities to support their efforts to develop new cancer treatments. Our client-centric approach to providing diagnostic services is driven by our belief that the practice of medicine and the delivery of healthcare are both personal and best delivered locally. With our extensive pathology expertise, Aurora Diagnostics is able to support comprehensive integrated approaches to patient care.
ePrimera is a East Brunswick, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
As the industry`s leading provider of innovative transfer center and on-call scheduling technology, Central Logic`s team works collaboratively with more than 430 hospitals and thousands of healthcare customers or relationships – including physicians, administrators, and healthcare staff – to design and implement patient flow software solutions that increase admissions and capacity. Founded in 2005, the company helps hospitals and systems measurably increase the number of patient admissions and patient transfer volumes while maximizing hospital staffing, efficiency and care coordination.
The healthcare industry is at a critical juncture, where every effort is being made to increase the effectiveness of care, while decreasing the financial burden on our system. With the introduction of BioTelemetry, we aim to lead in the advancement of mobile health monitoring by providing unmatched products and services to help healthcare professionals track and diagnose patients in a more efficient, accurate, and cost-effective manner. In April 2013, our predecessor company, CardioNet, Inc. (NASDAQ: BEAT), announced plans to adopt a holding company structure to more effectively facilitate our ongoing growth plans. With this change, our strategy is to achieve sustained long-term growth by solidifying our leadership position in remote cardiac monitoring, building a leading research services business, and identifying markets that would benefit from the application of our wireless platform and proprietary technology. We currently have four subsidiaries: CardioNet & Mednet- cardiac medical device & monitoring services, Braemar- cardiac manufacturing, Cardiocore- cardiac clinical research. Please visit our subsidiary pages for more information.
Columbia Analytical Services Inc is a Kelso, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.